Novo Nordisk
NVO
NVO
552 hedge funds and large institutions have $8.82B invested in Novo Nordisk in 2017 Q4 according to their latest regulatory filings, with 104 funds opening new positions, 144 increasing their positions, 173 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
12% more funds holding in top 10
Funds holding in top 10: 17 → 19 (+2)
0.67% more ownership
Funds ownership: 16.09% → 16.76% (+0.67%)
17% less repeat investments, than reductions
Existing positions increased: 144 | Existing positions reduced: 173
Holders
552
Holding in Top 10
19
Calls
$42.7M
Puts
$25.1M
Top Buyers
| 1 | +$391M | |
| 2 | +$106M | |
| 3 | +$73.5M | |
| 4 |
CGT
Capital Guardian Trust
Los Angeles,
California
|
+$38M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$31.2M |
Top Sellers
| 1 | -$98M | |
| 2 | -$47.1M | |
| 3 | -$37.7M | |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$22.7M |
| 5 |
F
Folketrygdfondet
Oslo Norway,
Norway
|
-$18.5M |